12:10 EDT Can-Fite BioPharma (CANF) trading halted, news pending
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CANF:
- Can-Fite BioPharma’s Piclidenoson Shows Promise in Vascular Dementia Treatment
- Can-Fite BioPharma announces group from UCLA demonstrate Piclidenoson efficacy
- Can-Fite BioPharma files to sell 4.9M American depositary shares
- Can-Fite BioPharma’s Shareholders Approve Key Proposals at Annual Meeting
- Can-Fite BioPharma Reschedules Annual Meeting Due to Lack of Quorum
